Income Statement (OCUPHIRE/PHARMA)

Technical Analysis Historical Data Financials News & Analysis

OCUPHIRE/PHARMA NEWS

HC Wainwright Reaffirms “Buy” Rating for Opus Genetics (NASDAQ:IRD) By MarketBeat - 4 days ago

Opus Genetics (NASDAQ:IRD – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga r… [+2899 chars]...

Read more
Opus Genetics (NASDAQ:IRD) Downgraded to “Sell” Rating by Wall Street Zen By MarketBeat - 4 days ago

Wall Street Zen downgraded shares of Opus Genetics (NASDAQ:IRD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. Other analysts also recently iss… [+2867 chars]...

Read more
Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements By Research - 1 week ago

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering. This report describes and… [+11183 chars]...

Read more
Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types By DelveInsight - 2 weeks ago

New York, USA, June 16, 2025 (GLOBE NEWSWIRE) -- Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsights analysis, the mar… [+9475 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		215.92 3.89
1.83%
CVX 		148.37 0.39
0.26%
CAT 		397.86 -0.57
-0.14%
INTC 		22.49 0.61
2.79%
MSFT 		498.84 7.75
1.58%
DIS 		124 1.02
0.83%
DOW 		28.46 -0.27
-0.94%
CSCO 		69.37 0.78
1.14%
GS 		723.68 7.79
1.09%